With Reports Of Death, FDA Warns Multiple Sclerosis (MS) Patients Against Pharmaceutical Drug Tysabri

Greg Jones & Associates, a North Carolina-based law firm, in association with launches a promoting campaign to increase awareness of the Multiple Sclerosis drug, Tysabri. Manufacturers of Tysabri, Biogen Idec Inc. and Elan Prescribed drugs Inc., have recently taken the drug off the market and sent out warnings to doctors.
In November 2004, Biogen Idec and Elan Corporation received approval from the FDA to plug and distribute Tysabri (natalizumab). Solely four months later, February 2005, the drug was quickly far from the market when the FDA received several reports of severe illness and death in patients prescribed Tysabri and Avonex. In many cases, the patient or corpse was diagnosed with Progressive Multifocal Leukoencephalopathy (PML), a rare brain infection that directly affects the central nervous system. Symptoms of PML are like a stroke: headaches, memory loss, speech and vision difficulties, limb weakness, and partial paralysis; the disease leads to coma then to death.
So far, approximately three,000 patients are involved in clinical trials or prescribed Tysabri for multiple sclerosis, Crohn's disease and rheumatoid arthritis. Biogen Idec and Elan Prescription drugs hope to redistribute the drug when intensive evaluations of Tysabri and the doable link to PML.
Biogen merged with IDEC Prescribed drugs in 2003, creating the billion-greenback company, Biogen Idec, that relies in Cambridge, Massachusetts. Biogen Idec also has another MS drug within the news: the bread-winning drug, Avonex, the foremost widely prescribed Multiple Sclerosis drug in the world with revenues of $1.four billion in 2004 has recently been linked to increased risk of liver injury and liver failure.
Greg Jones & Associates is urging patients that have had adverse aspect effects with the pharmaceuticals Tysabri or Avonex, to possess their case reviewed at every case can be evaluated by a lawyer at no charge.
For a lot of details concerning this product recall and potential category action lawsuit, visit

Article Source: http://www.newsarticlessite.com

submitarticle has been writing articles online for nearly 2 years now. Not only does this author specialize in Diseases Multiple Sclerosis You can also check out his latest website about : Starwars T ShirtWhich reviews and lists the best custom t shirt

Please Rate this Article

5 out of 54 out of 53 out of 52 out of 51 out of 5 

Not yet Rated